Vectus Biosystems Limited has released a press release.
FDA Pre-IND Meeting Request Granted for VB0004
Earlier from Vectus Biosystems
- Placement of Shares
- Appointment of Dr Tara Speranza as CEO & CTO
- VB4-P5 Renal Compound Transaction Settled
- Half Year Report & Appendix 4D